ReEmerge is developing Cognitive Network Restoration Therapy (CNRT) for people with chronic cognitive impairment after brain injury. The treatment targets underactive but viable neural circuits in the central thalamus to restore function across disrupted brain networks; the company is advancing this restorative approach through clinical development.
IC
IAG Capital Partners
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Healthtech · Jan 1, 2026
IAG Capital Partners is the Charleston investment firm identified in its own Xscape portfolio and investment announcement.
Recorded funding activity
The recorded activity includes Arcee’s open-weight models, ReEmerge’s therapy for chronic cognitive impairment and Cornelis’ high-speed computing-network fabrics. The full firm identity distinguishes it from unrelated angel and airline organizations using IAG.
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $99.5M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionReEmerge, Inc.
$37MSeries A
ParticipantElucid
Clinically validated medical-imaging software that analyzes CT angiography to characterize arterial plaque and help clinicians assess cardiovascular risk.
$55MSeries D
ParticipantNeurosoft Bioelectronics
Develops soft stretchable brain-computer interfaces using non-penetrating cortical electrodes for neural data acquisition
$7.5MSeed
Role not disclosed